The global ultrasensitive molecular amplification market is experiencing robust growth, driven by advances in diagnostic technologies and rising demand for precise detection of infectious and genetic ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...